Testing effectiveness (Phase 2)Ended earlyNCT00427973
What this trial is testing
AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer
Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 17